Not surprisingly, blockade of both interactions: CTLA-4/B7-1 and B7-2 with anti-CTLA-4 antibody, or PD-1/PD-L1 with either anti-PD-1 or anti-PD-L1 antibody resulted in decreased tumor size in unimmunized mice. Here, CD86 is linked to neoplasm.